XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid in Capital [Member]
Earnings Less than Distributions [Member]
Accumulated Other Comprehensive (Loss) Income [Member]
Noncontrolling Interest [Member]
Consolidated Joint Ventures [Member]
Noncontrolling Interest [Member]
Consolidated Real Estate Fund [Member]
Noncontrolling Interest [Member]
Operating Partnership [Member]
Beginning balance at Dec. 31, 2018 $ 4,891,664 $ 2,329 $ 4,201,756 $ (219,906) $ 16,621 $ 394,995 $ 66,887 $ 428,982
Common stock, shares outstanding at Dec. 31, 2018   233,136,000            
Net (loss) income 12,174     6,164   5,202 147 661
Common shares issued upon redemption of common units   $ 14 23,976          
Common shares issued upon redemption of common units   1,406,000            
Common shares issued under Omnibus share plan, net of shares withheld for taxes (307) $ 3   (310)        
Common shares issued under Omnibus share plan, net of shares withheld for taxes   56,000            
Repurchases of common shares (6,488) $ (5) (6,483)          
Repurchases of common shares, shares   (474,000)            
Dividends and distributions (51,902)     (46,887)       (5,015)
Contributions from noncontrolling interests 14,966           14,966  
Distributions to noncontrolling interests (34,919)         (34,919)    
Change in value of interest rate swaps (24,371)       (22,026)     (2,345)
Pro rata share of other comprehensive loss of unconsolidated joint ventures (184)       (120)   (51) (13)
Amortization of equity awards 12,756   1,340         11,416
Reallocation of noncontrolling interest     (6,396)         6,396
Ending balance at Jun. 30, 2019 4,813,389 $ 2,341 4,214,193 (260,939) (5,525) 365,278 81,949 416,092
Common stock, shares outstanding at Jun. 30, 2019   234,124,000            
Redemption of minority interest in operating partnerships               (23,990)
Beginning balance at Mar. 31, 2019 4,854,636 $ 2,345 4,218,060 (239,949) 8,421 367,012 81,434 417,313
Common stock, shares outstanding at Mar. 31, 2019   234,478,000            
Net (loss) income 5,174     2,455   2,408 53 258
Common shares issued upon redemption of common units   $ 1 2,007          
Common shares issued upon redemption of common units   118,000            
Common shares issued under Omnibus share plan, net of shares withheld for taxes (6)     (6)        
Common shares issued under Omnibus share plan, net of shares withheld for taxes   2,000            
Repurchases of common shares (6,488) $ (5) (6,483)          
Repurchases of common shares, shares   (474,000)            
Dividends and distributions (25,953)     (23,439)       (2,514)
Contributions from noncontrolling interests 470           470  
Distributions to noncontrolling interests (4,142)         (4,142)    
Change in value of interest rate swaps (15,345)       (13,884)     (1,461)
Pro rata share of other comprehensive loss of unconsolidated joint ventures (76)       (62)   (8) (6)
Amortization of equity awards 5,119   643         4,476
Reallocation of noncontrolling interest     (34)         34
Ending balance at Jun. 30, 2019 4,813,389 $ 2,341 4,214,193 (260,939) (5,525) 365,278 81,949 416,092
Common stock, shares outstanding at Jun. 30, 2019   234,124,000            
Redemption of minority interest in operating partnerships               (2,008)
Beginning balance at Dec. 31, 2019 $ 4,630,962 $ 2,274 4,133,184 (349,557) (171) 360,778 72,396 412,058
Common stock, shares outstanding at Dec. 31, 2019 227,432,030 227,432,000            
Repurchases of common shares $ (100,000)              
Repurchases of common shares, shares   (10,856,865)            
Ending balance at Mar. 31, 2020 4,507,192 $ 2,219 4,102,287 (368,767) (13,478) 359,120 80,476 345,335
Common stock, shares outstanding at Mar. 31, 2020   221,750,000            
Beginning balance at Dec. 31, 2019 $ 4,630,962 $ 2,274 4,133,184 (349,557) (171) 360,778 72,396 412,058
Common stock, shares outstanding at Dec. 31, 2019 227,432,030 227,432,000            
Net (loss) income $ (2,458)     (2,922)   1,919 (1,212) (243)
Common shares issued upon redemption of common units   $ 51 85,260          
Common shares issued upon redemption of common units   5,126,000            
Common shares issued under Omnibus share plan, net of shares withheld for taxes (316) $ 3   (319)        
Common shares issued under Omnibus share plan, net of shares withheld for taxes   63,000            
Repurchases of common shares (100,000) $ (109) (99,891)          
Repurchases of common shares, shares   (10,857,000)            
Dividends and distributions (48,634)     (44,422)       (4,212)
Contributions from noncontrolling interests 11,555         3,500 8,055  
Distributions to noncontrolling interests (6,357)         (6,357)    
Pro rata share of other comprehensive loss of unconsolidated joint ventures (16,357)       (14,860)   4 (1,501)
Amortization of equity awards 9,708   692         9,016
Reallocation of noncontrolling interest     (18,933)         18,933
Sale of a 10.0% interest in 1633 Broadway 109,573   33,230     76,343    
Ending balance at Jun. 30, 2020 $ 4,587,676 $ 2,219 4,133,542 (397,220) (15,031) 436,183 79,243 348,740
Common stock, shares outstanding at Jun. 30, 2020 221,763,687 221,764,000            
Redemption of minority interest in operating partnerships               (85,311)
Beginning balance at Mar. 31, 2020 $ 4,507,192 $ 2,219 4,102,287 (368,767) (13,478) 359,120 80,476 345,335
Common stock, shares outstanding at Mar. 31, 2020   221,750,000            
Net (loss) income (7,684)     (6,270)   405 (1,235) (584)
Common shares issued under Omnibus share plan, net of shares withheld for taxes (7)     (7)        
Common shares issued under Omnibus share plan, net of shares withheld for taxes   14,000            
Repurchases of common shares, shares   0            
Dividends and distributions (24,292)     (22,176)       (2,116)
Contributions from noncontrolling interests 3,500         3,500    
Distributions to noncontrolling interests (3,185)         (3,185)    
Pro rata share of other comprehensive loss of unconsolidated joint ventures (1,696)       (1,553)   2 (145)
Amortization of equity awards 4,275   294         3,981
Reallocation of noncontrolling interest     (2,269)         2,269
Sale of a 10.0% interest in 1633 Broadway 109,573   33,230     76,343    
Ending balance at Jun. 30, 2020 $ 4,587,676 $ 2,219 $ 4,133,542 $ (397,220) $ (15,031) $ 436,183 $ 79,243 $ 348,740
Common stock, shares outstanding at Jun. 30, 2020 221,763,687 221,764,000